Home
Market News
Breaking stock market headlines
Earnings Flash
Breaking coverage of earnings reports, forecasts & dividend updates
Trends
Market movers, trading patterns & key market indicators
Disclosures
Official filings & reports from listed Japanese companies
Explorer
Stock lists filtered by fundamental & technical metrics
GMO GlobalSign, Jan-Mar (1Q) Ordinary Profit Increases by 63%
3788 GMO GlobalSign Holdings K.K. 【J-GAAP】
Earnings ReportGMO GlobalSign Holdings K.K. <3788> [TSE Prime] announced its financial results after the market closed on May 14th (15:31). The consolidated ordinary profit for the first quarter of the fiscal year ending December 2026 (January to March) expanded 0.46 billion yen, an increase 63.3% compared to the same period last year. Progress toward the full-year plan of 1.58 billion yen was 29.1%, almost the same as the five-year average of 32.3%.
In the most recent three-month period, from January to March (1Q), the operating profit margin improved from 5.8% in the same period last year to 7.7%.
Kabutan News
Actual Results
| Fiscal Year | Revenue | Operating Profit | Ordinary Profit | Net Profit | Adj. EPS | Progress Rate vs. First Half | Announce | Accounting Standards |
|---|---|---|---|---|---|---|---|---|
| Jan - Mar, 2024 | 4,720 | 423 | 465 | 335 | 29.1 | 57.4 | May 10, 2024 | J-GAAP |
| Jan - Mar, 2025 | 4,909 | 285 | 283 | 202 | 17.6 | 49.0 | May 13, 2025 | J-GAAP |
| Jan - Mar, 2026 | 5,566 | 430 | 462 | 347 | 30.3 | ー | May 14, 2026 | J-GAAP |
| YoY | +13.4% | +50.9% | +63.3% | +71.8% | +71.8% |
Current Period Guidance
H1 Results
| Fiscal Year | Revenue | Operating Profit | Ordinary Profit | Net Profit | Adj. EPS | Adj. Dividend | Announce | Accounting Standards |
|---|---|---|---|---|---|---|---|---|
| Jan - Jun, 2025 | 9,944 | 593 | 577 | 413 | 36.0 | 0 | Aug 7, 2025 | J-GAAP |
| Jan - Jun, 2026 Guidance | ー | ー | ー | ー | - | 0 | Feb 10, 2026 | J-GAAP |
| YoY | - | - | - | - | - |
Current Period Guidance
| Fiscal Year | Revenue | Operating Profit | Ordinary Profit | Net Profit | Adj. EPS | Adj. Dividend | Announce | Accounting Standards |
|---|---|---|---|---|---|---|---|---|
| Dec, 2024 | 19,166 | 1,246 | 1,297 | 854 | 74.2 | 37.22 | Feb 12, 2025 | J-GAAP |
| Dec, 2025 | 20,670 | 1,475 | 1,435 | 1,005 | 87.6 | 56.91 | Feb 10, 2026 | J-GAAP |
| Dec, 2026 Guidance | 22,286 | 1,622 | 1,589 | 1,052 | 91.7 | 59.67 | Feb 10, 2026 | J-GAAP |
| YoY | +7.8% | +10.0% | +10.7% | +4.7% | +4.8% |
Quarterly Results
| Fiscal Year | Revenue | Operating Profit | Ordinary Profit | Net Profit | Adj. EPS | Operating Profit Margin | Announce | Accounting Standards |
|---|---|---|---|---|---|---|---|---|
| Jan - Mar, 2025 | 4,909 | 285 | 283 | 202 | 17.6 | 5.8 | May 13, 2025 | J-GAAP |
| Apr - Jun, 2025 | 5,035 | 308 | 294 | 211 | 18.4 | 6.1 | Aug 7, 2025 | J-GAAP |
| Jul - Sep, 2025 | 5,164 | 390 | 380 | 290 | 25.3 | 7.6 | Nov 12, 2025 | J-GAAP |
| Oct - Dec, 2025 | 5,562 | 492 | 478 | 302 | 26.3 | 8.8 | Feb 10, 2026 | J-GAAP |
| Jan - Mar, 2026 | 5,566 | 430 | 462 | 347 | 30.3 | 7.7 | May 14, 2026 | J-GAAP |
| YoY | +13.4% | +50.9% | +63.3% | +71.8% | +71.8% |
Related Articles
BrightPath Biotherapeutics, The Current Fiscal Year's Net Income to Widen
GMO TECH, Jan-Mar (1Q) Ordinary Profit 135 Million Yen
Dynamic Map, Last Fiscal Year's Ordinary Profit Loss Widens, Current period performance is undisclosed.
eWeLL, Jan-Mar (1Q) Ordinary Profit Increases by 15%
GMO Pepabo, Jan-Mar (1Q) Ordinary Profit Decreases by 13%
VELTRA, Jan-Mar (1Q) Net Income Turns to Loss
GMO Media, Jan-Mar (1Q) Ordinary Profit Decreases by 40%
GMO Commerce, Jan-Mar (1Q) Ordinary Profit 158 Million Yen
PRONI, Jan-Mar (1Q) Ordinary Profit 154 Million Yen
SHOEI YAKUHIN, 13% Decrease in Ordinary Profit for The Current Fiscal Year